NEW YORK (GenomeWeb) – Akonni Biosystems said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop molecular diagnostic tests for lower respiratory diseases in children.

The award, worth $225,000 and administered by the National Institute of Allergy and Infectious Diseases, is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.